Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Background: Consistent evidence is still lacking on which one, glimepiride plus metformin or repaglinide plus metformin, is better in treating type 2 diabetes mellitus (T2DM). Therefore, this study was conducted to compare the short-term efficacy and safety of these two methods in treating T2DM. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jing, Li, Ning, Jiang, Xiaoyan, Chai, Liyin, Chen, Jian-Jun, Deng, Wuquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489581/
https://www.ncbi.nlm.nih.gov/pubmed/31114280
http://dx.doi.org/10.2147/DMSO.S198154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489581/
https://www.ncbi.nlm.nih.gov/pubmed/31114280
http://dx.doi.org/10.2147/DMSO.S198154

Ejemplares similares